معرفی
Andrew Hattersley is the Gilling Chair of Precision Medicine and Professor of Molecular Medicine at the University of Exeter Medical School. He serves as Clinical Director of the Clinical Research Facility and has held significant leadership roles including Director of Research and Development at Royal Devon and Exeter Hospital (2007-2022). His work focuses on translating genetic discoveries into improved diabetes diagnosis and treatment.
- University of Oxford - D.M. (1997)
- University of Oxford - BM BCh (1984)
- University of Cambridge - BA (1981)
His research spans diabetes genetics, precision medicine, and beta-cell biology, with particular emphasis on monogenic diabetes, genetic discovery, and pharmacogenetics. His team of 25 researchers works on gene discovery, human physiology, clinical trials, and data informatics for diabetes treatment optimization.
His scientific achievements include over 650 peer-reviewed publications in top journals like Nature, Science, and NEJM, with >123,000 citations and an H-index of 160. Notable work includes establishing the fetal insulin hypothesis and demonstrating precision medicine applications in diabetes treatment.
- 2021 Hamm Prize for diabetes research
- 2020 Baillet Latour Health Prize
- 2018 Banting Memorial Lecture Award
- 2018 Dale Medal
- 2017 CBE for medical research
With >£92 million in grant funding from 103 individual awards, his current major funding includes Wellcome Trust, MRC, and NIHR grants. He leads a 25-person research team focusing on gene discovery, human physiology, and implementation research in diabetes.
